Author:
Kis Tamás,Hort Simon,Györgyi Péter,Szögi Evelin,Schmitt Robert H.
Reference19 articles.
1. Towards a commercial process for the manufacture of genetically modified T cells for therapy;Kaiser;Cancer Gene Ther.,2015
2. Global manufacturing of CAR T cell therapy;Levine;Mol Ther - Methods Clin Dev.,2017
3. Autologous CAR T-cell therapies supply chain: challenges and opportunities?;Papathanasiou;Cancer Gene Ther,2020
4. Iyer, R.K., Bowles, P.A., Kim, H., Dulgar-Tulloch, A.: Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges. Front. Med. 2018; 5:150. doi: 10.3389/fmed.2018.00150
5. A guide to manufacturing CAR T cell therapies;Vormittag;Current opinion in biotechnology,2018